{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:05Z","timestamp":1786985225003,"version":"build-2736575974"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["GAP-2192"],"award-info":[{"award-number":["GAP-2192"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["GAP-2176"],"award-info":[{"award-number":["GAP-2176"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["GAP-3103"],"award-info":[{"award-number":["GAP-3103"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008812","name":"Defence Science and Technology Group","doi-asserted-by":"publisher","award":["GAP-2191"],"award-info":[{"award-number":["GAP-2191"]}],"id":[{"id":"10.13039\/501100008812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108797","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:12Z","timestamp":1753890612000},"page":"108797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Exploring therapeutic strategies for candidiasis: From current treatments to future perspectives"],"prefix":"10.1016","volume":"164","author":[{"given":"Hadiya Amin","family":"Kantroo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Mosa","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahoor","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108797_bb0005","series-title":"StatPearls","author":"Rafiq","year":"2024"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jof7020079","article-title":"Candida Albicans\u2014the virulence factors and clinical manifestations of infection","volume":"7","author":"Talapko","year":"2021","journal-title":"J. Fungi"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0015","article-title":"The impact of the fungus-host-microbiota interplay upon Candida Albicans infections: current knowledge and new perspectives","volume":"45","author":"d\u2019Enfert","year":"2020","journal-title":"FEMS Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.resmic.2017.02.005","article-title":"Candida and its dual lifestyle as a commensal and a pathogen","volume":"168","author":"Cauchie","year":"2017","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108797_bb0025","first-page":"13","article-title":"Epidemiology and prevalence of Oral candidiasis in HIV patients from Chad in the post-HAART era","author":"Taverne-Ghadwal","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108797_bb0030","series-title":"Polymicrobial Diseases","article-title":"Interactions between candida species and bacteria in mixed infections","author":"Jenkinson","year":"2002"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/21505594.2021.2019950","article-title":"Pathogenesis and virulence of Candida Albicans","volume":"13","author":"Lopes","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.bioorg.2025.108797_bb0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12879-019-4260-4","article-title":"Chronic disseminated candidiasis manifesting as Hepatosplenic abscesses among patients with hematological malignancies","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019494","article-title":"A multicenter retrospective analysis of the antifungal susceptibility patterns of Candida species and the predictive factors of mortality in south Korean patients with Candidemia","volume":"99","author":"Jung","year":"2020","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0050","first-page":"20","article-title":"Candidemia: changing dynamics from a tertiary care hospital in North India","volume":"8","author":"Gautam","year":"2022","journal-title":"Curr. Med. Mycol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0055","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/antibiotics11060718","article-title":"Diagnosis and treatment of invasive candidiasis","volume":"11","author":"Barantsevich","year":"2022","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0060","article-title":"Native human and mouse skin infection models to study Candida Auris-host interactions","volume":"26","author":"Seiser","year":"2024","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bioorg.2025.108797_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/IDR.S80677","article-title":"Retrospective analysis of mortality and Candida isolates of 75 patients with Candidemia: a single hospital experience","volume":"8","author":"Hirano","year":"2015","journal-title":"Infect. Drug Resistance"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108797_bb0070","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.33073\/pjm-2022-036","article-title":"Opportunistic Candida infections in critical COVID-19 patients","volume":"71","author":"\u00c7avu\u015f","year":"2022","journal-title":"Pol. J. Microbiol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0085","doi-asserted-by":"crossref","first-page":"1612661","DOI":"10.1080\/21688370.2019.1612661","article-title":"Candida Albicans interactions with the host: crossing the intestinal epithelial barrier","volume":"7","author":"Basmaciyan","year":"2019","journal-title":"Tissue Barriers"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108797_bb0095","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3389\/fmicb.2018.01351","article-title":"Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents","volume":"9","author":"Santos","year":"2018","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108797_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/genes11070795","article-title":"Regulation of Ergosterol biosynthesis in saccharomyces cerevisiae","volume":"11","author":"Jord\u00e1","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.bioorg.2025.108797_bb0105","series-title":"Antifungal Ergosterol Synthesis Inhibitors","author":"Herrick","year":"2024"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0110","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1042\/bst0190774","article-title":"Squalene epoxidase as a target for the Allylamines","volume":"19","author":"Ryder","year":"1991","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108797_bb0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","article-title":"Therapy for fungal diseases: opportunities and priorities","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0120","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins \u2013 structure, mechanism of action and use in antifungal therapy","volume":"37","author":"Szyma\u0144ski","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2025.108797_bb0130","series-title":"Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine","article-title":"The Health and Economic Burden of Resistance","author":"National Academies of Sciences, E.; Division, H. and M.; Practice, B. on P. H. and P. H.; States, C. on the L.-T. H. and E. E. of A. R. in the U.; Palmer, G. H.; Buckley, G. J","year":"2021"},{"key":"10.1016\/j.bioorg.2025.108797_bb0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resistance"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0140","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal drug resistance: molecular mechanisms in Candida Albicans and beyond","volume":"121","author":"Lee","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108797_bb0145","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268823001346","article-title":"Fluconazole and Echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak","volume":"151","author":"Szekely","year":"2023","journal-title":"Epidemiol. Infect."},{"issue":"Suppl. 6","key":"10.1016\/j.bioorg.2025.108797_bb0150","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin. Infecti. Diseases: Official Publication Infect. Diseases Soc. Am."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/genes9090461","article-title":"Evolutionary emergence of drug resistance in Candida opportunistic pathogens","volume":"9","author":"Ksiezopolska","year":"2018","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0165","first-page":"323","article-title":"Candida Auris: the new fungal threat","volume":"31","author":"Pallotta","year":"2023","journal-title":"Infez. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108797_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz262","article-title":"Development of high-level Echinocandin resistance in a patient with recurrent Candida Auris Candidemia secondary to chronic Candiduria","volume":"6","author":"Biagi","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00238-18","article-title":"Understanding Echinocandin resistance in the emerging pathogen Candida Auris","volume":"62","author":"Kordalewska","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108797_bb0180","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/antibiotics9120877","article-title":"Drug-resistant Fungi: an emerging challenge threatening our limited antifungal armamentarium","volume":"9","author":"Arastehfar","year":"2020","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108797_bb0185","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/14656566.4.5.807","article-title":"Caspofungin: first approved agent in a new class of antifungals","volume":"4","author":"Johnson","year":"2003","journal-title":"Expert. Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108797_bb0190","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-Spectrum Triazole antifungal agent","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/jwh.2022.0132","article-title":"Oral Ibrexafungerp for vulvovaginal candidiasis treatment: an analysis of VANISH 303 and VANISH 306","volume":"32","author":"Goje","year":"2023","journal-title":"J. Women\u2019s Health"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s40265-022-01734-y","article-title":"Oteseconazole: First Approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/infdis\/jiae146","article-title":"Regulatory considerations in the approval of Rezafungin (Rezzayo) for the treatment of Candidemia and invasive candidiasis in adults","volume":"230","author":"Smith","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/microorganisms8020154","article-title":"Candida Albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal","volume":"8","author":"Costa-de-Oliveira","year":"2020","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108797_bb0215","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance","volume":"5","author":"Cowen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.18869\/acadpub.ibj.21.4.275","article-title":"Regulation of ERG3, ERG6, and ERG11 genes in antifungal-resistant isolates of Candida Parapsilosis","volume":"21","author":"Lotfali","year":"2017","journal-title":"Iran. Biomed. J."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0225","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/stresses4040041","article-title":"Ergosterol biosynthesis and regulation impact the antifungal resistance and virulence of Candida Spp","volume":"4","author":"Elia\u0161","year":"2024","journal-title":"Stresses"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0230","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1128\/AAC.47.9.2717-2724.2003","article-title":"Disruption of Ergosterol biosynthesis confers resistance to amphotericin B in Candida Lusitaniae","volume":"47","author":"Young","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11908-022-00782-5","article-title":"Antifungal resistance and the role of new therapeutic agents","volume":"24","author":"Logan","year":"2022","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.bioorg.2025.108797_bb0240","author":"Protein kinases as potential anticandidal drug targets"},{"key":"10.1016\/j.bioorg.2025.108797_bb0245","author":"Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition - PMC"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0250","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/EC.00279-10","article-title":"Candida Albicans Als3, a multifunctional Adhesin and Invasin","volume":"10","author":"Liu","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.bioorg.2025.108797_bb0255","author":"The HOG MAPK pathway in Candida albicans: more than an osmosensing pathway | International Microbiology"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0260","first-page":"6988","article-title":"Inhibiting roles of Farnesol and HOG in morphological switching of Candida Albicans","volume":"12","author":"Wang","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bioorg.2025.108797_bb0265","author":"Glyoxylate cycle gene ICL1 is essential for the metabolic flexibility and virulence of Candida glabrata | Scientific Reports"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095951","article-title":"Inhibitors of the Glyoxylate cycle enzyme ICL1 in Candida Albicans for potential use as antifungal agents","volume":"9","author":"Cheah","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108797_bb0275","author":"Calcium homeostasis is required for contact-dependent helical and sinusoidal tip growth in Candida albicans hyphae - PubMed"},{"key":"10.1016\/j.bioorg.2025.108797_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126786","article-title":"Calcium-Calcineurin signaling pathway in Candida Albicans: a potential drug target","volume":"249","author":"Li","year":"2021","journal-title":"Microbiol. Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108797_bb0285","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2958.2005.05037.x","article-title":"CRZ1, a target of the Calcineurin pathway in Candida Albicans","volume":"59","author":"Karababa","year":"2006","journal-title":"Mol. Microbiol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/fov016","article-title":"Calcineurin signaling: lessons from Candida species","volume":"15","author":"Yu","year":"2015","journal-title":"FEMS Yeast Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108797_bb0295","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/EC.00194-06","article-title":"Function of Candida Albicans Adhesin Hwp1 in biofilm formation","volume":"5","author":"Nobile","year":"2006","journal-title":"Eukaryot. Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.phymed.2011.08.060","article-title":"Comparison between Allicin and fluconazole in Candida Albicans biofilm inhibition and in suppression of HWP1 gene expression","volume":"19","author":"Khodavandi","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2025.108797_bb0305","author":"Extracellular hydrolytic enzyme activities of the different Candida spp. isolated from the blood of the Intensive Care Unit-admitted patients - PMC"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0310","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41467-021-22111-5","article-title":"Molecular basis of V-ATPase inhibition by Bafilomycin A1","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.6026\/97320630007125","article-title":"Selection of orlistat as a potential inhibitor for lipase from Candida species","volume":"7","author":"Khedidja","year":"2011","journal-title":"Bioinformation"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0320","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41467-025-57346-z","article-title":"Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida Albicans","volume":"16","author":"Puumala","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0325","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.3390\/ijms22094324","article-title":"A highlight on the inhibition of fungal carbonic anhydrases as drug targets for the antifungal armamentarium","volume":"22","author":"Supuran","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0330","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/metabo10010039","article-title":"Sulfonamide inhibition profile of the \u03b2-carbonic anhydrase from Malassezia Restricta, an opportunistic pathogen triggering scalp conditions","volume":"10","author":"Del Prete","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2025.108797_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bioorg.2019.01.030","article-title":"Benzenesulfonamides incorporating nitrogenous bases show effective inhibition of \u03b2-carbonic anhydrases from the pathogenic Fungi Cryptococcus Neoformans, Candida Glabrata and Malassezia Globosa","volume":"86","author":"Bua","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0340","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/acsinfecdis.0c00229","article-title":"Herbicides that target Acetohydroxyacid synthase are potent inhibitors of the growth of drug-resistant Candida Auris","volume":"6","author":"Agnew-Francis","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0345","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/jm301501k","article-title":"Sulfonylureas have antifungal activity and are potent inhibitors of Candida Albicans Acetohydroxyacid synthase","volume":"56","author":"Lee","year":"2013","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108797_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102068","article-title":"Structural characterization of fungus-specific histone deacetylase Hos3 provides insights into developing selective inhibitors with antifungal activity","volume":"298","author":"Pang","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108797_bb0355","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/jof8080875","article-title":"Epigenetic regulation of antifungal drug resistance","volume":"8","author":"Patra","year":"2022","journal-title":"J. Fungi"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0360","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/AAC.46.11.3532-3539.2002","article-title":"Histone deacetylase inhibitors enhance Candida Albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation","volume":"46","author":"Smith","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1568005033342064","article-title":"Chitin synthesis as target for antifungal drugs","volume":"3","author":"Ruiz-Herrera","year":"2003","journal-title":"Curr. Drug Targets Infect. Disord."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108797_bb0370","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/jb.178.8.2416-2419.1996","article-title":"Role of three chitin synthase genes in the growth of Candida Albicans","volume":"178","author":"Mio","year":"1996","journal-title":"J. Bacteriol."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2025.108797_bb0375","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/mmy.39.1.41.53","article-title":"Chitin synthesis in human pathogenic Fungi","volume":"39","author":"Munro","year":"2001","journal-title":"Med. Mycol."},{"key":"10.1016\/j.bioorg.2025.108797_bb0380","author":"General Principles of Preclinical Study Design | SpringerLink"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0385","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions","volume":"13","author":"Ovung","year":"2021","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.bioorg.2025.108797_bb0390","doi-asserted-by":"crossref","unstructured":"Rohilla, S.; Sharma, D. Chapter 2 - sulfonamides, quinolones, antiseptics, and disinfectants. In Medicinal Chemistry of Chemotherapeutic Agents; Acharya, P. C., Kurosu, M., Eds.; Academic Press, 2023; pp. 21\u201363. doi:https:\/\/doi.org\/10.1016\/B978-0-323-90575-6.00015-6.","DOI":"10.1016\/B978-0-323-90575-6.00015-6"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/eri.09.117","article-title":"Sulfonamides and trimethoprim","volume":"8","author":"Sk\u00f6ld","year":"2010","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108797_bb0400","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.3390\/molecules23123129","article-title":"Synthesis and evaluation of new 1,3,4-Thiadiazole derivatives as potent antifungal agents","volume":"23","author":"Karaburun","year":"2018","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0405","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/molecules22111926","article-title":"Syntheses of novel 4-substituted N-(5-amino-1H-1,2,4-Triazol-3-Yl)Pyridine-3-sulfonamide derivatives with potential antifungal activity","volume":"22","author":"Szafra\u0144ski","year":"2017","journal-title":"Mol.\u00a0: J. Synthetic Chem. Nat. Product Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108797_bb0410","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1007\/s11164-017-2956-x","article-title":"A new class of Arylsulfonamide-based 3-Acetyl-2-Methyl-4-Phenylquinolines and in vitro evaluation of their antioxidant, antifungal, and antibacterial activities","volume":"43","author":"Jyothish Kumar","year":"2017","journal-title":"Res. Chem. Intermed."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0415","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.arabjc.2017.10.009","article-title":"Synthesis of novel Naphtho[1,2-e][1,3]Oxazines bearing an Arylsulfonamide moiety and their anticancer and antifungal activity evaluations","volume":"13","author":"Mansouri","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108797_bb0420","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejmech.2013.01.034","article-title":"Synthesis, biological evaluation of new Oxazolidino-sulfonamides as potential antimicrobial agents","volume":"62","author":"Kamal","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0425","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/microorganisms11061522","article-title":"Evaluation of the in vitro antifungal activity of novel Arylsulfonamides against Candida Spp","volume":"11","author":"Ginestra","year":"2023","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0430","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/jhet.3647","article-title":"Synthesis and antimicrobial and antioxidant activities of sulfonamide derivatives containing Tetrazole and Oxadiazole rings","volume":"56","author":"\u00d6zkan","year":"2019","journal-title":"J. Heterocyclic Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0435","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/md20020144","article-title":"Secondary metabolites from marine sponges of the genus Oceanapia: chemistry and biological activities","volume":"20","author":"Xu","year":"2022","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108797_bb0440","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/ml200020h","article-title":"Natural product based 6-Hydroxy-2,3,4,6-Tetrahydropyrrolo[1,2-a]Pyrimidinium scaffold as a new antifungal template","volume":"2","author":"Li","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108797_bb0445","author":"Synthesis and Antifungal Activity Evaluation of Phloeodictine Analogues - PubMed"},{"issue":"21","key":"10.1016\/j.bioorg.2025.108797_bb0450","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1021\/acs.jmedchem.1c01299","article-title":"Optimization and evaluation of novel antifungal agents for the treatment of fungal infection","volume":"64","author":"Choi","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108797_bb0455","series-title":"Journal of Chromatography Library","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0301-4770(02)80020-3","article-title":"Chapter 19 - derivatization reactions for Analytes with various functional groups","volume":"65","author":"Moidoveanu","year":"2002"},{"key":"10.1016\/j.bioorg.2025.108797_bb0460","author":"Antibiotics | Free Full-Text | Antifungal Properties of Hydrazine-Based Compounds against Candida albicans"},{"issue":"13","key":"10.1016\/j.bioorg.2025.108797_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127220","article-title":"Design, synthesis and evaluation of hydrazine and acyl Hydrazone derivatives of 5-Pyrrolidin-2-one as antifungal agents","volume":"30","author":"Dascalu","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108797_bb0470","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acsinfecdis.1c00404","article-title":"Identification of inhibitors of fungal fatty acid biosynthesis","volume":"7","author":"DeJarnette","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0475","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/molecules24010184","article-title":"A novel series of Acylhydrazones as potential anti-Candida agents: design, synthesis, biological evaluation and in silico studies","volume":"24","author":"Borcea","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108797_bb0480","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.molstruc.2019.02.045","article-title":"Synthesis, chemical characterization and antimicrobial activity of new Acylhydrazones derived from carbohydrates","volume":"1184","author":"Guilherme","year":"2019","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0485","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.3390\/molecules26113166","article-title":"Thiazole ring\u2014a biologically active scaffold","volume":"26","author":"Petrou","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0490","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.farmac.2004.03.001","article-title":"Synthesis and in vitro antifungal activity of 4-substituted Phenylguanidinium salts","volume":"59","author":"Braunerov\u00e1","year":"2004","journal-title":"Farmaco"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108797_bb0495","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.bmcl.2011.04.075","article-title":"Novel fungicidal Benzylsulfanyl-Phenylguanidines","volume":"21","author":"Thevissen","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108797_bb0500","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1021\/acs.jmedchem.1c00883","article-title":"Identification of Thiazoyl guanidine derivatives as novel antifungal agents inhibiting Ergosterol biosynthesis for treatment of invasive fungal infections","volume":"64","author":"Kato","year":"2021","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0505","first-page":"286","article-title":"Synthesis of Benzothiazolyl Guanidinyl derivatives and their in-vitro antimicrobial and antioxidant activity","volume":"7","author":"Bhat","year":"2017","journal-title":"Nat. Prod. J."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108797_bb0510","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.3390\/molecules23102522","article-title":"New N-(Oxazolylmethyl)-thiazolidinedione active against Candida Albicans biofilm: potential Als proteins inhibitors","volume":"23","author":"Marc","year":"2018","journal-title":"Mol.: J. Synthetic Chem. Nat. Prod. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108797_bb0515","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1007\/s11164-014-1871-7","article-title":"Design, synthesis, and biological evaluation of Thiourea and guanidine derivatives of Pyrimidine-6-carboxylate","volume":"41","author":"Malik","year":"2015","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2025.108797_bb0520","doi-asserted-by":"crossref","first-page":"101","DOI":"10.15227\/orgsyn.032.0101","volume":"32","author":"THIOBENZOIC ACID","year":"1952","journal-title":"Org. Synth."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0525","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3181\/00379727-115-28869","article-title":"Antimicrobial activity of Thiobenzoate and its O-Fluoro- and M-Fluoro-derivatives","volume":"115","author":"Gale","year":"1964","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0530","first-page":"297","article-title":"Effect of Thiobenzoate on Cytolo\u01f5y of Candida Albicans","volume":"36","author":"Gale","year":"1964","journal-title":"Microbiology"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108797_bb0535","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/acsinfecdis.1c00270","article-title":"Identification of dual-target compounds with antifungal and anti-NLRP3 Inflammasome activity","volume":"7","author":"Lowes","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.108797_bb0540","article-title":"Beta-Carboline as a promising heterocyclic nucleus: synthetic aspects, pharmacological potential and structure activity relationship","volume":"6","author":"Thatikayala","year":"2022","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108797_bb0545","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/ml400492t","article-title":"Novel Carboline derivatives as potent antifungal Lead compounds: design, synthesis, and biological evaluation","volume":"5","author":"Wang","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0550","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/acs.jmedchem.0c01763","article-title":"Novel Carboline fungal histone deacetylase (HDAC) inhibitors for combinational treatment of azole-resistant candidiasis","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126869","article-title":"Design, synthesis and bio-evaluation of C-1 alkylated Tetrahydro-\u03b2-Carboline derivatives as novel antifungal Lead compounds","volume":"30","author":"Singh","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0560","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/s41467-021-26390-w","article-title":"A small molecule produced by Lactobacillus species blocks Candida Albicans Filamentation by inhibiting a DYRK1-family kinase","volume":"12","author":"MacAlpine","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108797_bb0565","doi-asserted-by":"crossref","unstructured":"Mor, V.; Rella, A.; Farnoud, A. M.; Singh, A.; Munshi, M.; Bryan, A.; Naseem, S.; Konopka, J. B.; Ojima, I.; Bullesbach, E.; Ashbaugh, A.; Linke, M. J.; Cushion, M.; Collins, M.; Ananthula, H. K.; Sallans, L.; Desai, P. B.; Wiederhold, N. P.; Fothergill, A. W.; Kirkpatrick, W. R.; Patterson, T.; Wong, L. H.; Sinha, S.; Giaever, G.; Nislow, C.; Flaherty, P.; Pan, X.; Cesar, G. V.; de Melo Tavares, P.; Frases, S.; Miranda, K.; Rodrigues, M. L.; Luberto, C.; Nimrichter, L.; Del Poeta, M. Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids. mBio 2015, 6 (3), https:\/\/doi.org\/10.1128\/mbio.00647-15. doi:https:\/\/doi.org\/10.1128\/mbio.00647-15.","DOI":"10.1128\/mBio.00647-15"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108797_bb0570","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00156-18","article-title":"Acylhydrazones as antifungal agents targeting the synthesis of fungal sphingolipids","volume":"62","author":"Lazzarini","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108797_bb0575","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1021\/acs.jmedchem.9b01004","article-title":"SAR studies on aromatic Acylhydrazone-based inhibitors of fungal sphingolipid synthesis as next-generation antifungal agents","volume":"62","author":"Haranahalli","year":"2019","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0580","doi-asserted-by":"crossref","first-page":"e00920","DOI":"10.1128\/AAC.00946-20","article-title":"Preclinical evaluation of Acylhydrazone SB-AF-1002 as a novel broad-Spectrum antifungal agent","volume":"64","author":"Lazzarini","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.108797_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117610","article-title":"SAR study of N\u2019-(Salicylidene)Heteroarenecarbohydrazides as promising antifungal agents","volume":"100","author":"Sun","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0590","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/jof7020130","article-title":"Review of T-2307, an investigational agent that causes collapse of fungal mitochondrial membrane potential","volume":"7","author":"Wiederhold","year":"2021","journal-title":"J. Fungi"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0595","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00003-23","article-title":"Recent Progress in research on mitochondrion-targeted antifungal drugs: a review","volume":"67","author":"Qin","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0600","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.01159-07","article-title":"In vitro and in vivo antifungal activities of T-2307, a novel Arylamidine","volume":"52","author":"Mitsuyama","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.108797_bb0605","first-page":"11","article-title":"ATI-2307 exhibits equivalent antifungal activity in Cryptococcus Neoformans clinical isolates with high and Low fluconazole IC50","author":"Gerlach","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2025.108797_bb0610","first-page":"59","article-title":"The novel Arylamidine T-2307 maintains in vitro and in vivo activity against Echinocandin resistant Candida Albicans","author":"Wiederhold","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0615","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/AAC.05954-11","article-title":"T-2307 causes collapse of mitochondrial membrane potential in yeast","volume":"56","author":"Shibata","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108797_bb0620","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00374-19","article-title":"The novel Arylamidine T-2307 selectively disrupts yeast mitochondrial function by inhibiting respiratory chain complexes","volume":"63","author":"Yamashita","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0625","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00446834","article-title":"Stoffwechselprodukte von Mikroorganismen","volume":"107","author":"D\u00e4hn","year":"1976","journal-title":"Arch. Microbiol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0630","first-page":"775","article-title":"Mechanism of action of Nikkomycin and the peptide transport system of Candida Albicans","volume":"131","author":"McCarthy","year":"1985","journal-title":"J. Gen. Microbiol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108797_bb0635","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","article-title":"Modeling Nikkomycin Z dosing and pharmacology in murine pulmonary Coccidioidomycosis preparatory to phase 2 clinical trials","volume":"209","author":"Shubitz","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0640","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/AAC.43.6.1401","article-title":"In vitro antifungal activity of Nikkomycin Z in combination with fluconazole or Itraconazole","volume":"43","author":"Li","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0645","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11046-023-00788-0","article-title":"Synergy in vitro of Nikkomycin Z with azole against the invasive form of Candida Albicans","volume":"188","author":"Sass","year":"2023","journal-title":"Mycopathologia"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0650","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/lam.13204","article-title":"Synergistic effect of Nikkomycin Z with Caspofungin and micafungin against Candida Albicans and Candida Parapsilosis biofilms","volume":"69","author":"Kov\u00e1cs","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0655","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/yea.837","article-title":"Inhibitory effect of Nikkomycin Z on chitin synthases in Candida Albicans","volume":"19","author":"Kim","year":"2002","journal-title":"Yeast"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0660","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/acsmedchemlett.5b00029","article-title":"Generation of broad-Spectrum antifungal drug candidates from the natural product compound Aureobasidin a","volume":"6","author":"Wuts","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108797_bb0665","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/AAC.00633-08","article-title":"Inhibition of inositol Phosphorylceramide synthase by the cyclic peptide Aureobasidin a","volume":"53","author":"Aeed","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108797_bb0670","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/jof9111115","article-title":"Structural and functional alterations caused by Aureobasidin a in clinical resistant strains of Candida Spp","volume":"9","author":"Rollin-Pinheiro","year":"2023","journal-title":"Journal of Fungi"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108797_bb0675","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","article-title":"Biological properties of Aureobasidin a, a cyclic Depsipeptide antifungal antibiotic","volume":"46","author":"Takesako","year":"1993","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108797_bb0680","doi-asserted-by":"crossref","first-page":"e00123","DOI":"10.1128\/cmr.00142-23","article-title":"Advancements and challenges in antifungal therapeutic development","volume":"37","author":"Puumala","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0685","doi-asserted-by":"crossref","first-page":"285","DOI":"10.29252\/iem.6.4.285","article-title":"Antifungal activity of Aureobasidin a in combination with fluconazole against fluconazole-resistant Candida Albicans","volume":"6","author":"Alimehr","year":"2020","journal-title":"Infect. Epidemiol. Microbiol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108797_bb0690","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/pathogens10070856","article-title":"Sphingolipid inhibitors as an alternative to treat candidiasis caused by fluconazole-resistant strains","volume":"10","author":"Rollin-Pinheiro","year":"2021","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0695","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/AAC.44.3.651-653.2000","article-title":"Inhibition of inositol Phosphorylceramide synthase by Aureobasidin a in Candida and Aspergillus species","volume":"44","author":"Zhong","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0700","article-title":"Fosmanogepix: the novel anti-fungal agent\u2019s comprehensive review of in vitro, in vivo, and current insights from advancing clinical trials","volume":"16","author":"Almajid","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0705","doi-asserted-by":"crossref","first-page":"e01622","DOI":"10.1128\/aac.01623-22","article-title":"Safety and pharmacokinetics of intravenous and Oral Fosmanogepix, a first-in-class antifungal agent, in healthy volunteers","volume":"67","author":"Hodges","year":"2023","journal-title":"Antimicrobial Agent Chemotherapy"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108797_bb0710","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00656-20","article-title":"Manogepix (APX001A) in vitro activity against Candida Auris: head-to-head comparison of EUCAST and CLSI MICs","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0715","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1365-2958.2003.03481.x","article-title":"Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal Cell Wall assembly","volume":"48","author":"Tsukahara","year":"2003","journal-title":"Mol. Microbiol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0720","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: a review of the first-in-class broad Spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J. Fungi"},{"key":"10.1016\/j.bioorg.2025.108797_bb0725","author":"Biosergen | Innovative Antifungal Drugs"},{"key":"10.1016\/j.bioorg.2025.108797_bb0730","author":"Munilakshmi. Biosergen and Alkem to launch BSG005 clinical studies in India. Clinical Trials Arena"},{"key":"10.1016\/j.bioorg.2025.108797_bb0735","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/IDR.S372546","article-title":"Salvage treatment for invasive aspergillosis and Mucormycosis: challenges, recommendations and future considerations","volume":"16","author":"Egger","year":"2023","journal-title":"Infect. Drug Resistance"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108797_bb0740","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1128\/AAC.00270-13","article-title":"Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group","volume":"57","author":"Tevyashova","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.108797_bb0745","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/pharmaceutics16081065","article-title":"Polyene-based derivatives with antifungal activities","volume":"16","author":"Ngece","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.108797_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114969","article-title":"Reviving the interest in the versatile drug nystatin: a multitude of strategies to increase its potential as an effective and safe antifungal agent","volume":"199","author":"Sousa","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108797_bb0755","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae032","article-title":"Safety and Pharmacokinetics of Antifungal Agent VT-1598 and Its Primary Metabolite, VT-11134, in Healthy Adult Subjects: Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled Study of Single-Ascending Oral Doses of VT-1598","volume":"62","author":"Gu","year":"2024","journal-title":"Med. Mycol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0760","doi-asserted-by":"crossref","first-page":"e02218","DOI":"10.1128\/AAC.02233-18","article-title":"The fungal Cyp51-specific inhibitor VT-1598 demonstrates in vitro and in vivo activity against Candida Auris","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108797_bb0765","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijantimicag.2017.09.002","article-title":"The antifungal arsenal: alternative drugs and future targets","volume":"51","author":"Wiederhold","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108797_bb0770","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/jac\/dky170","article-title":"VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant Oral candidiasis in IL-17 Signalling-deficient mice","volume":"73","author":"Break","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108797_bb0775","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00341-19","article-title":"In vitro activities of the novel investigational Tetrazoles VT-1161 and VT-1598 compared to the Triazole antifungals against azole-resistant strains and clinical isolates of Candida Albicans","volume":"63","author":"Nishimoto","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.108797_bb0780","author":"Drug repurposing from the perspective of pharmaceutical companies - PMC"},{"key":"10.1016\/j.bioorg.2025.108797_bb0785","author":"Tamoxifen - StatPearls - NCBI Bookshelf"},{"key":"10.1016\/j.bioorg.2025.108797_bb0790","author":"Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization - PMC"},{"key":"10.1016\/j.bioorg.2025.108797_bb0795","author":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis | Journal of Antimicrobial Chemotherapy | Oxford Academic"},{"key":"10.1016\/j.bioorg.2025.108797_bb0800","author":"Antifungal Activity and Mode of Action of Miltefosine Against Clinical Isolates of Candida krusei - PMC"},{"key":"10.1016\/j.bioorg.2025.108797_bb0805","author":"Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens - PMC"},{"key":"10.1016\/j.bioorg.2025.108797_bb0810","author":"Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development - PubMed"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:28:22Z","timestamp":1762223302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":162,"alternative-id":["S0045206825006777"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108797","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring therapeutic strategies for candidiasis: From current treatments to future perspectives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108797"}}